Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.020 CAD
−4.57 M CAD
1.07 M CAD
229.90 M
About THERALASE TECHNOLOGIES INC
Sector
Industry
CEO
Roger J. Dumoulin-White
Website
Headquarters
Toronto
Founded
1989
FIGI
BBG000BDZ9K8
Theralase Technologies, Inc. engages in the design, development, and manufacture of patented laser technology platforms used in bio-stimulative and bio-destructive clinical applications in patients. It operates through the Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT) segments. The ACT segment covers the research and development of photo dynamic compounds (PDCs) for the treatment of cancer. The CLT segment is responsible for the company’s medical laser business, which researches, develops, manufactures, and distributes CLT systems to healthcare practitioners predominantly for the healing of pain. The company was founded by Roger J. Dumoulin-White on August 22, 1989 and is headquartered in Toronto, Canada.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of TLT is 0.250 CAD — it has decreased by −7.41% in the past 24 hours. Watch THERALASE TECHNOLOGIES INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange THERALASE TECHNOLOGIES INC stocks are traded under the ticker TLT.
TLT stock has fallen by −3.85% compared to the previous week, the month change is a −13.79% fall, over the last year THERALASE TECHNOLOGIES INC has showed a 47.06% increase.
We've gathered analysts' opinions on THERALASE TECHNOLOGIES INC future price: according to them, TLT price has a max estimate of 0.80 CAD and a min estimate of 0.80 CAD. Watch TLT chart and read a more detailed THERALASE TECHNOLOGIES INC stock forecast: see what analysts think of THERALASE TECHNOLOGIES INC and suggest that you do with its stocks.
TLT stock is 19.57% volatile and has beta coefficient of −1.39. Track THERALASE TECHNOLOGIES INC stock price on the chart and check out the list of the most volatile stocks — is THERALASE TECHNOLOGIES INC there?
Today THERALASE TECHNOLOGIES INC has the market capitalization of 61.95 M, it has increased by 2.66% over the last week.
Yes, you can track THERALASE TECHNOLOGIES INC financials in yearly and quarterly reports right on TradingView.
THERALASE TECHNOLOGIES INC is going to release the next earnings report on Apr 23, 2025. Keep track of upcoming events with our Earnings Calendar.
TLT earnings for the last quarter are 0.00 CAD per share, whereas the estimation was 0.00 CAD resulting in a −48.15% surprise. The estimated earnings for the next quarter are 0.00 CAD per share. See more details about THERALASE TECHNOLOGIES INC earnings.
THERALASE TECHNOLOGIES INC revenue for the last quarter amounts to 346.58 K CAD, despite the estimated figure of 346.60 K CAD. In the next quarter, revenue is expected to reach 150.00 K CAD.
TLT net income for the last quarter is −937.53 K CAD, while the quarter before that showed −1.13 M CAD of net income which accounts for 17.31% change. Track more THERALASE TECHNOLOGIES INC financial stats to get the full picture.
No, TLT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. THERALASE TECHNOLOGIES INC EBITDA is −4.09 M CAD, and current EBITDA margin is −402.51%. See more stats in THERALASE TECHNOLOGIES INC financial statements.
Like other stocks, TLT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade THERALASE TECHNOLOGIES INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So THERALASE TECHNOLOGIES INC technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating THERALASE TECHNOLOGIES INC stock shows the buy signal. See more of THERALASE TECHNOLOGIES INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.